HAVCR2 and B-cell chronic lymphocytic leukemia: Moreover, a recent study found that both galectin-9 and TIM-3 were elevated in the regulatory T cells of patients with CLL in the Binet C stage [16], indicating that the TIM-3/galectin-9 interaction may be associated with poor prognosis in patients with CLL.